Solvo Biotechnology  

6 September 2006

   Newsletter

SOLVO Biotechnology is launching the new Mouse Bsep and MRP5 Vesicular transport assays now!

The newest ABC membrane transporter products - Mouse Bsep and MRP5 vesicular transport assays are now available directly from SOLVO or from our distributors.

The standard Vesicular Transport assay is an indirect inhibitory-type assay, and is performed with cold test compounds. It provides information on any interaction between the ABC transporter and the test drug that would affect the transport of the reporter substrate (radioactive compound). In this assay the transport of a known substrate - the reporter substrate - is measured in the presence of the test drug. Values are presented on a relative scale with 100% defined as transport in the absence of the test compound (no inhibition), and 0% defined as transport measured in the absence of ATP (no transporter activity). IC50 is defined as the concentration required to inhibit the transport of the reporter substrate by 50%.


Mouse Bsep Vesicular Transport Assay

Taurocholate, the reporter substrate used by SOLVO's mouse Bsep VT assay, is the major endogenous substrate of Bsep. In SOLVO's indirect mouse Bsep vesicular transport assay the interaction of compounds with mouse Bsep is detected as the inhibition of the transport of 3H-Taurocholate, therefore the assay shows the effect of the test drug on the physiological function of the transporter. The assay utilizes Sf9 cell membranes containing mouse Bsep. Expession of the protein is achieved by baculoviral transfection.


ATP dependent mouse Bsep mediated transport of 3H-Taurocholate at different concentrations of various test compounds.

MRP5 Vesicular Transport Assay

The endogenous substrates of MRP5 are cyclic nucleoside monophosphates, such as cAMP and cGMP.  Therefore, MRP5 may play a role in the regulation of signal transduction by transporting these second messengers out of the cells. As MRP5 is present in blood vessels, inhibition of cGMP transport can elongate the duration of vasodilatation, making MRP5 a target in conditions like hypertonia, angina pectoris, congestive heart failure, and acute pulmonary edema and erectile dysfunction.
SOLVO's protocol for measuring vesicular transport on mammalian cell membranes expressing MRP5 utilizes 3H-cGMP as substrate.


ATP dependent MRP5 mediated transport of 3H-cGMP at different concentrations of various test compounds

The mouse Bsep and MRP5 Vesicular Transport Assays are either available as a products (SB-mouseBsep-Sf9-VT and SB-MRP5-HEL293-VT membrane preparation) for in house screening or as the Fee-For-Service Screening performed in the SOLVO Screening Laboratory.

Best regards,
SOLVO Biotechnology
Business Development Team



For Customers in Japan: Funakoshi (distributor of SOLVO membrane products) Iwaki (exclusive distributor of SOLVO Fee-for Service Screenings, distributor of SOLVO membrane products)
Privileged/confidential information may be contained in this message. This communication is confidential and intended solely for the addressee(s). Unauthorized distribution, modification or disclosure of the contents may be unlawful. If you receive this in error, please notify the sender and delete it from your system. If you are not the addressee indicated in this message (or responsible for delivery of the message to such person), you may not copy or deliver this message to anyone.
If you wish to unsubscribe, please send a letter to with 'unsubscribe' in the subject field.